Premium
[O2‐03‐04]: Development of a new class of orally bioavailable and safe experimental therapeutics that attenuate disease progression in an Alzheimer's disease‐related mouse model
Author(s) -
Van Eldik Linda J.,
Craft Jeffrey M.,
Hu Wenhui,
Ranaivo Hantamalala Ralay,
Watterson D. Martin
Publication year - 2005
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2005.06.345
Subject(s) - neuroinflammation , pharmacology , in vivo , hippocampal formation , inflammation , neurodegeneration , medicine , neuroscience , neuroprotection , alzheimer's disease , disease , biology , immunology , pathology , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom